Sila Realty Trust Files 8-K
Ticker: SILA · Form: 8-K · Filed: Dec 16, 2024 · CIK: 1567925
Sentiment: neutral
Topics: disclosure, real-estate
TL;DR
Sila Realty Trust filed an 8-K on 12/16/2024 for a Reg FD disclosure.
AI Summary
Sila Realty Trust, Inc. filed an 8-K on December 16, 2024, reporting a Regulation FD Disclosure. The filing does not contain specific financial figures or transaction details in the provided text, but it indicates a formal disclosure event.
Why It Matters
This filing signals a material event or disclosure by Sila Realty Trust, Inc. to the public, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard disclosure document without immediate negative or positive financial implications presented in the text.
Key Players & Entities
- Sila Realty Trust, Inc. (company) — Registrant
- December 16, 2024 (date) — Date of Report
- Maryland (jurisdiction) — State of Incorporation
- Tampa, Florida (location) — Principal Executive Offices
- Carter Validus Mission Critical REIT II, Inc. (company) — Former Company Name
FAQ
What is the specific nature of the Regulation FD Disclosure made by Sila Realty Trust, Inc. on December 16, 2024?
The provided text of the 8-K filing does not specify the exact nature of the Regulation FD Disclosure, only that it was filed on December 16, 2024.
What was Sila Realty Trust, Inc.'s former company name?
Sila Realty Trust, Inc.'s former company name was Carter Validus Mission Critical REIT II, Inc.
In which state is Sila Realty Trust, Inc. incorporated?
Sila Realty Trust, Inc. is incorporated in Maryland.
What is the principal executive office address for Sila Realty Trust, Inc.?
The principal executive office address for Sila Realty Trust, Inc. is 1001 Water St. Suite 800, Tampa, Florida 33602.
What is the SEC file number for Sila Realty Trust, Inc.?
The SEC file number for Sila Realty Trust, Inc. is 001-42129.
Filing Stats: 832 words · 3 min read · ~3 pages · Grade level 12.1 · Accepted 2024-12-16 16:54:45
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value per share SILA New York Stock
- $1.7 m — he Yucca Valley Healthcare Facility was $1.7 million, and the Company generated net pr
- $1.6 m — generated net proceeds of approximately $1.6 million, after transaction costs, subject
- $150.0 million — 024 and an aggregate notional amount of $150.0 million. Additionally, on December 6, 2024, the
- $100.0 million — 024 and an aggregate notional amount of $100.0 million. The four swaps have a maturity date of
- $250.0 million — ps with an aggregate notional amount of $250.0 million that have a maturity date of December 3
Filing Documents
- cik0001567925-20241216.htm (8-K) — 28KB
- 0001567925-24-000113.txt ( ) — 153KB
- cik0001567925-20241216.xsd (EX-101.SCH) — 2KB
- cik0001567925-20241216_lab.xml (EX-101.LAB) — 22KB
- cik0001567925-20241216_pre.xml (EX-101.PRE) — 13KB
- cik0001567925-20241216_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. GenesisCare Update As previously disclosed by Sila Realty Trust, Inc. (the "Company"), GenesisCare USA, Inc. and its affiliates ("GenesisCare"), the sponsor and owner of the tenant in certain of the Company's real estate properties, announced that it filed for Chapter 11 bankruptcy protection under the United States Bankruptcy Code on June 1, 2023 and emerged from bankruptcy on February 16, 2024. On October 24, 2024, the Company entered into a contract for sale with a buyer for the Yucca Valley Healthcare Facility, which was previously leased to GenesisCare. On December 10, 2024, the Company, through a wholly-owned subsidiary of its operating partnership, Sila Realty Operating Partnership, LP (the "Operating Partnership"), completed the sale of the Yucca Valley Healthcare Facility. The contractual sales price of the Yucca Valley Healthcare Facility was $1.7 million, and the Company generated net proceeds of approximately $1.6 million, after transaction costs, subject to additional transaction costs that will be paid subsequent to the closing date. On December 13, 2024, the Company, through a wholly-owned subsidiary of the Operating Partnership (the "Landlord"), entered into a new triple-net lease agreement (the "Lease Agreement"), effective December 13, 2024, with the Regents of the University of California (the "Tenant") for the El Segundo Healthcare Facility, which was previously leased to GenesisCare. The Lease Agreement has an initial 10-year term, subject to two consecutive 5-year renewal options exercisable by the Tenant (subject to certain conditions). Interest Rate Swap Agreements On November 27, 2024, the Company entered into two interest rate swap agreements, which have an effective date of December 31, 2024 and an aggregate notional amount of $150.0 million. Additionally, on December 6, 2024, the Company entered into two interest rate swap agreements, which have an effective date of December 31, 2024 and an aggreg